Arianne Perez

Arianne Perez currently serves as the Global Head of Cell Therapy Clinical Pharmacology and Safety Sciences at AstraZeneca, a position held since January 2025. Prior experience includes serving as Senior Vice President and Vice President of Translational Sciences at Neogene Therapeutics from January 2021 to June 2025, and various roles at Kite Pharma from February 2014 to January 2021, including Senior Director of R&D. Arianne's career began with postdoctoral roles at Columbia University Medical Center and NYU Medical Center, focusing on T-cell lymphoblastic leukemia and T-cell mediated antitumor responses, respectively. Arianne holds a Ph.D. in Genetics from Universitat de Barcelona and a Master's degree in Scientific, Medical, and Environmental Communication from Universitat Pompeu Fabra.